Furthermore, tumours expressing TFR‐1, could be also targeted by drugs able to modulate intracellular iron oxidative state (Daniels, Delgado, Helguera, et al., 2006; Daniels, Delgado, Rodriguez, et al., 2006), in order to induce ferroptosis in malignant cells. The gene discussed is TFRC; the disease is neoplasm.